Related references
Note: Only part of the references are listed.Inflammatory bowel disease and irritable bowel syndrome: similarities and differences
Giovanni Barbara et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
The meaning of low-grade inflammation in clinically quiescent inflammatory bowel disease
Alan C. Moss
CURRENT OPINION IN GASTROENTEROLOGY (2014)
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Aleksandar D. Kostic et al.
GASTROENTEROLOGY (2014)
Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation
M. Vivinus-Nebot et al.
GUT (2014)
The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models
Rebeca Martin et al.
INFLAMMATORY BOWEL DISEASES (2014)
Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis
E. Varela et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Interleukin-4-and Interleukin-13-Mediated Alternatively Activated Macrophages: Roles in Homeostasis and Disease
Steven J. Van Dyken et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Differential Role of Lipocalin 2 During Immune ComplexMediated Acute and Chronic Inflammation in Mice
Rangaiah Shashidharamurthy et al.
ARTHRITIS AND RHEUMATISM (2013)
Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent
Laura Wrzosek et al.
BMC BIOLOGY (2013)
Regulation of intestinal epithelial permeability by tight junctions
Takuya Suzuki
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Sealing the Broken Barrier in IBD: Intestinal Permeability, Epithelial Cells and Junctions
Walter Fries et al.
CURRENT DRUG TARGETS (2013)
Faecalibacterium prausnitzii and human intestinal health
S. Miquel et al.
CURRENT OPINION IN MICROBIOLOGY (2013)
Th22 and related cytokines in inflammatory and autoimmune diseases
Tian Tian et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis
Anders H. Carlsson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria
G. Clarke et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Stephen J. Halpin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease
R. Kiesslich et al.
GUT (2012)
Regulation of inflammation by interleukin-4: a review of alternatives
Irina G. Luzina et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Microbes and the gut-brain axis
P. Bercik et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats
Hong-Yan Qin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
The shifting interface between IBS and IBD
Robin Spiller et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome
Mirjana Rajilic-Stojanovic et al.
GASTROENTEROLOGY (2011)
Sensitization to Gliadin Induces Moderate Enteropathy and Insulitis in Nonobese Diabetic-DQ8 Mice
Heather J. Galipeau et al.
JOURNAL OF IMMUNOLOGY (2011)
The intestinal microbiota and chronic disorders of the gut
Andrew W. DuPont et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Irritable Bowel Syndrome, Gut Microbiota and Probiotics
Beom Jae Lee et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Analysis of real-time serotonin (5-HT) availability during experimental colitis in mouse
Paul P. Bertrand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Loss of Prolyl Hydroxylase-1 Protects Against Colitis Through Reduced Epithelial Cell Apoptosis and Increased Barrier Function
Murtaza M. Tambuwala et al.
GASTROENTEROLOGY (2010)
Pathogenic Factors Involved in the Development of Irritable Bowel Syndrome: Focus on a Microbial Role
Carolina M. Bolino et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Diagnosis and management of IBS
Sarah Khan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Cytokine regulation of tight junctions
Christopher T. Capaldo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
The tight junction in inflammatory disease: communication breakdown
Karen L. Edelblum et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Towards the human intestinal microbiota phylogenetic core
Julien Tap et al.
ENVIRONMENTAL MICROBIOLOGY (2009)
Mechanism of cytokine modulation of epithelial tight junction barrier
Rana Al-Sadi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
The NIH Human Microbiome Project
Jane Peterson et al.
GENOME RESEARCH (2009)
Some immunomodulatory effects of probiotic bacteria might be due to porcine neutrophil elastase inhibitor, a serpin present in MRS broth
Maria C. Urdaci et al.
IMMUNOLOGY LETTERS (2009)
Host Responses to Intestinal Microbial Antigens in Gluten-Sensitive Mice
Jane M. Natividad et al.
PLOS ONE (2009)
Irritable bowel syndrome: towards biomarker identification
Gerard Clarke et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Analysis of bacterial bowel communities of IBD patients: What has it revealed?
Harry Sokol et al.
INFLAMMATORY BOWEL DISEASES (2008)
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of cytokines in inflammatory bowel disease
Fausto Sanchez-Munoz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
IFN-γ and TNF-α decrease serotonin transporter function and expression in Caco2 cells
Kevin F. Foley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome
L. Ohman et al.
DIGESTIVE AND LIVER DISEASE (2007)
Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans
Yu Wang et al.
CLINICAL CHEMISTRY (2007)
Flagellin suppresses epithelial apoptosis and limits disease during enteric infection
Matam Vijay-Kumar et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Irritable bowel syndrome
N. J. Talley
INTERNAL MEDICINE JOURNAL (2006)
Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse
M. D. Coates et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Inflammation as a cause of functional bowel disorders
H Törnblom et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis
DR Linden et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
Share Paper
